PCRX
Pacira Biosciences Inc
Price:  
25.88 
USD
Volume:  
529,298.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PCRX Stock Forecast & Price Target

PCRX Stock Price Forecast

The average stock forecast for Pacira Biosciences Inc (PCRX) in the next 12 months is 29.58 USD. This price target corresponds to an upside of 11.20%. The range of stock forecasts for PCRX is 23.23 - 39.90 USD. Based on the ratings of 13 analysts, the consensus recommendation for PCRX is BUY.
Target Low Average Median High
Price (USD) 23.23 29.58 28.05 39.90
Upside -12.67% 11.20% 5.45% 50.00%

Recommendation Trends

The latest consensus rating for PCRX is "BUY". This is the average recommendation of 13 analysts: 0 strong sell, 1 sell, 3 hold, 6 buy, 3 strong buy. In the previous period, 12 analysts also majorly recommmended "BUY" for PCRX.

PCRX Financial Stock Forecast

Revenue This Year
767.47M
5.65%
from 726.41M
Revenue Next Year
801.61M
4.45%
from 767.47M
EPS This Year
2.94
1,545.57%
from 0.18
EPS Next Year
3.52
19.62%
from 2.94